Search

Your search keyword '"Patrizi, Annalisa"' showing total 2,227 results
Start Over Author "Patrizi, Annalisa"
2,227 results on '"Patrizi, Annalisa"'

55. Contact allergy in children with and without atopic dermatitis: An Italian multicentre study

Author

Bonamonte, Domenico, Hansel, Katharina, Romita, Paolo, Fortina, Anna Belloni, Girolomoni, Giampiero, Fabbrocini, Gabriella, Patruno, Cataldo, Napolitano, Maddalena, Patrizi, Annalisa, Argenziano, Giuseppe, Micali, Giuseppe, Calzavara Pinton, Piergiacomo, Foti, Caterina, Stingeni, Luca, Italian Society of Dermatology and Venereology, Pediatric Dermatology Group: Chiara Barlusconi, Francesco Bellinato, Stefano Caccavale, Giulia Calabrese, Francesca Caroppo, Aurora De Marco, Angela Filoni, Rossella Marietti, Maria Rita Nasca, Iria Neri, Donatella Schena, Marta Tramontana, Annalisa Vascellaro, Bonamonte, Domenico, Hansel, Katharina, Romita, Paolo, Fortina, Anna Belloni, Girolomoni, Giampiero, Fabbrocini, Gabriella, Patruno, Cataldo, Napolitano, Maddalena, Patrizi, Annalisa, Argenziano, Giuseppe, Micali, Giuseppe, Calzavara Pinton, Piergiacomo, Foti, Caterina, Stingeni, Luca, Italian Society of Dermatology and Venereology, Pediatric Dermatology Group: Chiara Barlusconi, Francesco, Bellinato, Caccavale, Stefano, Giulia, Calabrese, Francesca, Caroppo, Aurora De Marco, Angela, Filoni, Rossella, Marietti, Maria Rita Nasca, Iria, Neri, Donatella, Schena, Marta, Tramontana, Annalisa, Vascellaro, Bonamonte, D., Hansel, K., Romita, P., Fortina, A. B., Girolomoni, G., Fabbrocini, G., Patruno, C., Napolitano, M., Patrizi, A., Argenziano, G., Micali, G., Calzavara Pinton, P., Foti, C., Stingeni, L., Barlusconi, C., Bellinato, F., Caccavale, S., Calabrese, G., Caroppo, F., De Marco, A., Filoni, A., Marietti, R., Nasca, M. R., Neri, I., Schena, D., Tramontana, M., and Vascellaro, A.

Subjects
atopic dermatiti, Male, Allergic Contact, atopic dermatitis, children, contact allergy, patch testing, Allergens, Child, Female, Humans, Patch Tests, Potassium Dichromate, Prevalence, Retrospective Studies, Dermatitis, Allergic Contact, Dermatitis, Atopic, Dermatitis, Dermatology, Atopic, Retrospective Studie, Immunology and Allergy, Patch Test, Allergen, Contact allergy, Human
Abstract

Background: Contact allergy and atopic dermatitis (AD) are both common inflammatory T cell-mediated diseases and many factors may influence the prevalence of contact allergy in AD patients. In children, their possible correlation was debated with conflicting results. Objectives: The present study aimed to assess the prevalence of contact sensitivity in children and to investigate the association with AD. Materials and methods: A retrospective multicentre study on children aged from 0 to 14 years patch tested between January 2017 and December 2018 was performed. Children were consecutively patch tested with the SIDAPA (Società Italiana Dermatologia Allergologica Professionale Ambientale) baseline series. Results: Among the 432 children investigated for contact allergy, 125 (28.9%) showed a positive reaction to at least one of the allergens tested, with a higher prevalence of positive patch test reactions in girls (32.3%) than in boys (25.0%). The most frequent contact allergens were nickel sulphate (10.2%), cobalt chloride (6.7%), methylisothiazolinone (3.7%), fragrance mix-2 (3.2%), potassium dichromate (2.8%), fragrance mix-1 (2.1%) and methylchloroisothiazolinone/methylisothiazolinone (2.1%). One-hundred-three children (23.8%) suffered from AD showing a higher prevalence of positive patch test (36.9%) compared to children without AD (26.4%). Conclusions: Despite the topic being still controversial, the present study suggests a consistent prevalence of contact allergy among children with higher sensitivity rate among children with AD than without AD.

Published
2022

64. National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis

Author

Gori, Niccolò, primary, Chiricozzi, Andrea, additional, Marsili, Franco, additional, Ferrucci, Silvia Mariel, additional, Amerio, Paolo, additional, Battarra, Vincenzo, additional, Campitiello, Salvatore, additional, Castelli, Antonio, additional, Congedo, Maurizio, additional, Corazza, Monica, additional, Cristaudo, Antonio, additional, Fabbrocini, Gabriella, additional, Girolomoni, Giampiero, additional, Malara, Giovanna, additional, Micali, Giuseppe, additional, Palazzo, Giovanni, additional, Parodi, Aurora, additional, Patrizi, Annalisa, additional, Pellacani, Giovanni, additional, Pigatto, Paolo, additional, Provenzano, Eugenio, additional, Quaglino, Pietro, additional, Romanelli, Marco, additional, Rossi, Mariateresa, additional, Savoia, Paola, additional, and Peris, Ketty, additional

Published
2022
Full Text
View/download PDF

67. Anogenital involvement: Clinical sign of severity in hidradenitis suppurativa

Author

Caposiena Caro, Raffaele Dante, primary, Molinelli, Elisa, additional, Rosi, Elia, additional, Chiricozzi, Andrea, additional, Venturini, Marina, additional, Sechi, Andrea, additional, Candi, Eleonora, additional, Brisigoti, Valerio, additional, Patrizi, Annalisa, additional, Calzavara-Pinton, Piergiacomo, additional, Peris, Ketty, additional, Prignano, Francesca, additional, Offidani, Annamaria, additional, and Bianchi, Luca, additional

Published
2022
Full Text
View/download PDF

69. Use of Apremilast® in the psoriasis treatment: a real-life multicenter Italian experience

Author

FILIPPI, Federica, primary, PATRIZI, Annalisa, additional, IEZZI, Luca, additional, CARPANESE, Miriam A., additional, CONTI, Andrea, additional, LASAGNI, Claudia, additional, TABANELLI, Michela, additional, D’ADAMIO, Simone, additional, DI NUZZO, Sergio, additional, CORTELAZZI, Chiara, additional, DI LERNIA, Vito, additional, PECCERILLO, Francesca, additional, CORAZZA, Monica, additional, ODORICI, Giulia, additional, and BARDAZZI, Federico, additional

Published
2022
Full Text
View/download PDF

74. Flares as dynamic predictive factor of response to adalimumab in hidradenitis suppurativa: real-life data

Author

Caposiena Caro, Raffaele D, Chiricozzi, Andrea, Sechi, Andrea, Molinelli, Elisa, Venturini, Marina, Candi, Eleonora, Malvaso, Dalma, Peris, Ketty, Patrizi, Annalisa, Offidani, Annamaria, Calzavara-Pinton, Piergiacomo, Bianchi, Luca, Chiricozzi, Andrea (ORCID:0000-0002-6739-0387), Peris, Ketty (ORCID:0000-0002-5237-0463), Caposiena Caro, Raffaele D, Chiricozzi, Andrea, Sechi, Andrea, Molinelli, Elisa, Venturini, Marina, Candi, Eleonora, Malvaso, Dalma, Peris, Ketty, Patrizi, Annalisa, Offidani, Annamaria, Calzavara-Pinton, Piergiacomo, Bianchi, Luca, Chiricozzi, Andrea (ORCID:0000-0002-6739-0387), and Peris, Ketty (ORCID:0000-0002-5237-0463)

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is characterized by periodic worsening of both clinical manifestations and symptoms. The aim of this study was to investigate the role of flare outbreak as a possible predictive factor of response to adalimumab. METHODS: One hundred fifteen HS patients in treatment with adalimumab, with moderate-severe HS, 3 abscesses and inflammatory-nodules (ANs) from 5 Italian centers were included in this retrospective analysis. The information about gender, ages at onset/baseline, therapeutic delay, family history, body mass index, smoking, comorbidities, phenotypes, body areas, severity indexes at baseline was collected. Baseline characteristics, total number and timeline of flares were analyzed by regression and survival analysis with Hidradenitis Suppurativa Clinical Response (HiSCR). RESULTS: During the observational period, 80.9% of patients developed flares, detecting 252 flares. Univariate model identified five factors as-sociated with the absence of response: age (P=0.020), comorbidities (P=0.030), genital-perineal involvement (P=0.004), no response at week 12 (P=0.027), and flares outbreak (P=0.010). Joint analysis of recurrent and terminal events showed a positive correlation between flare recurrence and no response (P<0.001). Among the identified variables associated with poor response to the therapy: occurrence of a flare before week 12 was the one with the highest risk of no response (P<0.001). CONCLUSIONS: The analysis of a "dynamic" variable, as flares evaluation together with an appropriate clinical baseline assessment can be a useful approach to predict the middle-long-term response to adalimumab. (Cite this article as: Caposiena Caro RD, Chiricozzi A, Sechi A, Molinelli E, Venturini M, Candi E, et al. Flares as dynamic predictive factor of re-sponse to adalimumab in hidradenitis suppurativa, real-life data. Ital J Dermatol Venereol 2022;157:240-6. DOI: 10.23736/S2784-8671.21.07049-3)

Published
2022

84. Blue toe syndrome: A challenging diagnosis

Author

Tartari, Federico, Altobrando, Ambra, Merli, Yuri, Patrizi, Annalisa, Mirelli, Michele, and Bianchi, Tommaso

Subjects
Angiography, Etiology (Medicine), Cyanosis, Health
Abstract

Byline: Federico. Tartari, Ambra. Altobrando, Yuri. Merli, Annalisa. Patrizi, Michele. Mirelli, Tommaso. Bianchi Sir, 'Blue toe syndrome' (BTS) refers to the acute onset of purple painful digits in the absence [...]

Published
2019

86. Granuloma Annulare

Author

Patrizi, Annalisa, Neri, Iria, Patrizi, Annalisa, and Neri, Iria

Abstract

Granuloma annulare (GA) is an inflammatory dermatosis of adults and children, arranged by groups of skin‐coloured to erythematous papules in an annular distribution. Nodular lesions may be present too. Common sites of GA are the extensor surfaces of the limbs, dorsa of hands and feet; scalp and trunk are rarely affected. The aetiology of GA is unclear, but some pathological associations have been reported, such as diabetes mellitus type 1, infections, haematological and autoimmune disorders. Four main clinical variants of GA are known: localized GA (multiple or single), subcutaneous GA, generalized GA (annular or nonannular) and perforating GA. Adjunctive rare variants are papular umbilicated GA and linear GA. Clinical features are crucial for suspecting GA, but in doubtful cases biopsy and histopathology are mandatory to confirm the diagnosis. Three main microscopic patterns have been described: palisading granulomatous, interstitial histiocytic and sarcoidal. GA is usually benign and self‐limiting so clinical follow‐up represents the first‐choice therapeutic option. Other topical or systemic measures have shown controversial results.

Published
2019
Full Text
View/download PDF

87. Flares as dynamic predictive factor of response to adalimumab in hidradenitis suppurativa: real-life data

Author

CAPOSIENA CARO, Raffaele D., primary, CHIRICOZZI, Andrea, additional, SECHI, Andrea, additional, MOLINELLI, Elisa, additional, VENTURINI, Marina, additional, CANDI, Eleonora, additional, MALVASO, Dalma, additional, PERIS, Ketty, additional, PATRIZI, Annalisa, additional, OFFIDANI, Annamaria, additional, CALZAVARA-PINTON, Piergiacomo, additional, and BIANCHI, Luca, additional

Published
2022
Full Text
View/download PDF

90. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry

Author

Chiricozzi, Andrea, Talamonti, Marina, De Simone, Clara, Galluzzo, Marco, Gori, Niccolò, Fabbrocini, Gabriella, Marzano, Angelo Valerio, Girolomoni, Giampiero, Offidani, Annamaria, Rossi, Maria Teresa, Bianchi, Luca, Cristaudo, Antonio, Fierro, Maria Teresa, Stingeni, Luca, Pellacani, Giovanni, Argenziano, Giuseppe, Patrizi, Annalisa, Pigatto, Paolo, Romanelli, Marco, Savoia, Paola, Rubegni, Pietro, Foti, Caterina, Milanesi, Nicola, Belloni Fortina, Anna, Bongiorno, Maria Rita, Grieco, Teresa, Di Nuzzo, Sergio, Fargnoli, Maria Concetta, Carugno, Andrea, Motolese, Alberico, Rongioletti, Franco, Amerio, Paolo, Balestri, Riccardo, Potenza, Concetta, Micali, Giuseppe, Patruno, Cataldo, Zalaudek, Iris, Lombardo, Maurizio, Feliciani, Claudio, Di Nardo, Lucia, Guarneri, Fabrizio, Peris, Ketty, Caldarola, Giacomo, Silvaggio, Dionisio, Dattola, Annunziata, Napolitano, Maddalena, Ferrucci, Silvia Mariel, Dal Bello, Giacomo, Bianchelli, Tommaso, Rovati, Chiara, Pigliacelli, Flavia, Ortoncelli, Michela, Hansel, Katharina, Calabrese, Giulia, Loi, Camilla, Iannone, Michela, Veronese, Federica, Romita, Paolo, Tronconi, Greta, Caroppo, Francesca, Tilotta, Giovanna, Sernicola, Alvise, Esposito, Maria, Raponi, Francesca, Gualdi, Giulio, Rech, Giulia, Musumeci, Maria Letizia, Nisticò, Steven Paul, Campitiello, Alessio, Bonzano, Laura, Piras, Viviana, Chiricozzi, A., Talamonti, M., De Simone, C., Galluzzo, M., Gori, N., Fabbrocini, G., Marzano, A. V., Girolomoni, G., Offidani, A., Rossi, M. T., Bianchi, L., Cristaudo, A., Fierro, M. T., Stingeni, L., Pellacani, G., Argenziano, G., Patrizi, A., Pigatto, P., Romanelli, M., Savoia, P., Rubegni, P., Foti, C., Milanesi, N., Belloni Fortina, A., Bongiorno, M. R., Grieco, T., Di Nuzzo, S., Fargnoli, M. C., Carugno, A., Motolese, A., Rongioletti, F., Amerio, P., Balestri, R., Potenza, C., Micali, G., Patruno, C., Zalaudek, I., Lombardo, M., Feliciani, C., Di Nardo, L., Guarneri, F., Peris, K., Caldarola, G., Silvaggio, D., Dattola, A., Napolitano, M., Ferrucci, S. M., Dal Bello, G., Bianchelli, T., Rovati, C., Pigliacelli, F., Ortoncelli, M., Hansel, K., Calabrese, G., Loi, C., Iannone, M., Veronese, F., Romita, P., Tronconi, G., Caroppo, F., Tilotta, G., Sernicola, A., Esposito, M., Raponi, F., Gualdi, G., Rech, G., Musumeci, M. L., Nistico, S. P., Campitiello, A., Bonzano, L., Piras, V., Chiricozzi, Andrea, Talamonti, Marina, De Simone, Clara, Galluzzo, Marco, Gori, Niccolò, Fabbrocini, Gabriella, Marzano, Angelo Valerio, Girolomoni, Giampiero, Offidani, Annamaria, Rossi, Maria Teresa, Bianchi, Luca, Cristaudo, Antonio, Fierro, Maria Teresa, Stingeni, Luca, Pellacani, Giovanni, Argenziano, Giuseppe, Patrizi, Annalisa, Pigatto, Paolo, Romanelli, Marco, Savoia, Paola, Rubegni, Pietro, Foti, Caterina, Milanesi, Nicola, Belloni Fortina, Anna, Bongiorno, Maria Rita, Grieco, Teresa, Di Nuzzo, Sergio, Fargnoli, Maria Concetta, Carugno, Andrea, Motolese, Alberico, Rongioletti, Franco, Amerio, Paolo, Balestri, Riccardo, Potenza, Concetta, Micali, Giuseppe, Patruno, Cataldo, Zalaudek, Iri, Lombardo, Maurizio, Feliciani, Claudio, Di Nardo, Lucia, Guarneri, Fabrizio, Peris, Ketty, Caldarola, Giacomo, Silvaggio, Dionisio, Dattola, Annunziata, Napolitano, Maddalena, Ferrucci, Silvia Mariel, Dal Bello, Giacomo, Bianchelli, Tommaso, Rovati, Chiara, Pigliacelli, Flavia, Ortoncelli, Michela, Hansel, Katharina, Calabrese, Giulia, Loi, Camilla, Iannone, Michela, Veronese, Federica, Romita, Paolo, Tronconi, Greta, Caroppo, Francesca, Tilotta, Giovanna, Sernicola, Alvise, Esposito, Maria, Raponi, Francesca, Gualdi, Giulio, Rech, Giulia, Musumeci, Maria Letizia, Nisticò, Steven Paul, Campitiello, Alessio, Bonzano, Laura, Piras, Viviana, Chiricozzi, A, Talamonti, M, De Simone, C, Galluzzo, M, Gori, N, Fabbrocini, G, Marzano, A, Girolomoni, G, Offidani, A, Rossi, M, Bianchi, L, Cristaudo, A, Fierro, M, Stingeni, L, Pellacani, G, Argenziano, G, Patrizi, A, Pigatto, P, Romanelli, M, Savoia, P, Rubegni, P, Foti, C, Milanesi, N, Belloni Fortina, A, Bongiorno, M, Grieco, T, Di Nuzzo, S, Fargnoli, M, Carugno, A, Motolese, A, Rongioletti, F, Amerio, P, Balestri, R, Potenza, C, Micali, G, Patruno, C, Zalaudek, I, Lombardo, M, Feliciani, C, Di Nardo, L, Guarneri, F, Peris, K, Caldarola, G, Silvaggio, D, Dattola, A, Napolitano, M, Ferrucci, S, Dal Bello, G, Bianchelli, T, Rovati, C, Pigliacelli, F, Ortoncelli, M, Hansel, K, Calabrese, G, Loi, C, Iannone, M, Veronese, F, Romita, P, Tronconi, G, Caroppo, F, Tilotta, G, Sernicola, A, Esposito, M, Raponi, F, Gualdi, G, Rech, G, Musumeci, M, Nistico, S, Campitiello, A, Bonzano, L, and Piras, V

Subjects
Registrie, 0301 basic medicine, Dermatitis, Systemic therapy, 0302 clinical medicine, Pandemic, Immunology and Allergy, Medicine, Registries, atopic dermatitis, COVID, SARS‐ CoV, treatment, SARS-CoV, Atopic dermatitis, Dupilumab, Italy, Original Article, Settore MED/35 - MALATTIE CUTANEE E VENEREE, Human, atopic dermatiti, Adult, medicine.medical_specialty, Teledermatology, SARS‐CoV, atopic dermatitis, treatment, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immunology, Communicable Disease Control, Humans, Pandemics, SARS-CoV-2, COVID-19, Dermatitis, Atopic, Atopic, 03 medical and health sciences, Settore MED/35, Disease severity, Internal medicine, business.industry, medicine.disease, 030104 developmental biology, 030228 respiratory system, atopic dermatitis, COVID, SARS-CoV, business
Abstract

Background Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID‐19) pandemic. Methods A national registry, named DA‐COVID‐19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID‐19 pandemic on the management of adult AD patients treated with systemic immunomodulant/immunosuppressive medications or phototherapy. Demographic and clinical data were obtained at different timepoints by teledermatology during COVID‐19 pandemic, when regular visits were not allowed due to sanitary restrictions. Disease severity was assessed by both physician‐ and patient‐reported assessment scores evaluating itch intensity, sleep disturbances, and AD severity. Results A total of 1831 patients were included, with 1580/1831 (86.3%) continuing therapy during pandemic. Most patients were treated with dupilumab (86.1%, 1576/1831) that was interrupted in only 9.9% (156/1576) of cases, while systemic immunosuppressive compounds were more frequently withdrawn. Treatment interruption was due to decision of the patient, general practitioner, or dermatologist in 39.9% (114/286), 5.6% (16/286), and 30.1% (86/286) of cases, respectively. Fear of increased susceptibility to SARS‐CoV‐2 infection (24.8%, 71/286) was one of the main causes of interruption. Sixteen patients (0.9%) resulted positive to SARS‐CoV‐2 infection; 3 of them (0.2%) were hospitalized but no cases of COVID‐related death occurred. Conclusions Most AD patients continued systemic treatments during COVID pandemic and lockdown period, without high impact on disease control, particularly dupilumab‐treated patients., Among 1831 studied AD patients, 86.1% were treated with dupilumab. Patients continuing therapy experienced a marked reduction of disease severity during pandemic. The causes of treatment interruption included: fear of increased susceptibility to SARS‐CoV‐2 infection (24.8%), occurrence of comorbidities (5.9%), age above 60 years (5.2%), SARS‐CoV‐2 infection (2.8%), close contact with SARS‐CoV‐2‐positive subject (2.4%), other reasons, for example, inability to maintain drug supply, non‐medical/unspecified causes (58.7%).

Published
2021

91. Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)

Author

de Bruin-Weller, Marjolein, primary, Pink, Andrew E., additional, Ferrucci, Silvia M., additional, Patrizi, Annalisa, additional, Svensson, Ake, additional, Schuttelaar, Marie L. A., additional, Tauber, Marie, additional, Ardeleanu, Marius, additional, Jayawardena, Shyamalie, additional, and Daoud, Moataz, additional

Published
2022
Full Text
View/download PDF

93. Unusual dermoscopic patterns of basal cell carcinoma mimicking melanoma

Author

Di Matteo, Eleonora, primary, Pampena, Riccardo, additional, Pizzichetta, Maria A., additional, Cinotti, Elisa, additional, Chester, Johanna, additional, Kaleci, Shaniko, additional, Manfredini, Marco, additional, Guida, Stefania, additional, Dika, Emi, additional, Moscarella, Elvira, additional, Lallas, Aimilios, additional, Apalla, Zoe, additional, Argenziano, Giuseppe, additional, Perrot, Jian L, additional, Tognetti, Linda, additional, Lai, Michela, additional, Cantisani, Carmen, additional, Roberti, Vincenzo, additional, Fiorani, Diletta, additional, Baraldi, Carlotta, additional, Veneziano, Leonardo, additional, Papageorgiou, Chryssoula, additional, Ciardo, Silvana, additional, Rubegni, Pietro, additional, Zalaudek, Iris, additional, Patrizi, Annalisa, additional, Longo, Caterina, additional, Bianchi, Luca, additional, Pellacani, Giovanni, additional, and Farnetani, Francesca, additional

Published
2022
Full Text
View/download PDF

100. Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey

Author

CASSANO, Nicoletta, primary, GENOVESE, Giovanni, additional, ASERO, Riccardo, additional, CRIMI, Nunzio, additional, CRISTAUDO, Antonio, additional, DAPAVO, Paolo, additional, DE PITÀ, Ornella, additional, FERRUCCI, Silvia, additional, FIERRO, Maria T., additional, FOTI, Caterina, additional, GIROLOMONI, Giampiero, additional, NETTIS, Eustachio, additional, OFFIDANI, Annamaria, additional, PATRIZI, Annalisa, additional, PEPE, Patrizia, additional, PIGATTO, Paolo, additional, STINGENI, Luca, additional, MARZANO, Angelo V., additional, and VENA, Gino A., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results